InvestSMART

Recce Pharmaceuticals Ltd (ASX: RCE) - Announcements

Current share price for RCE : $0.335 0.005 (1.52%)+

ASX company news and announcements for Recce Pharmaceuticals Ltd (RCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Recce Pharmaceuticals Ltd (RCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Recce Pharmaceuticals Ltd (RCE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Recce Pharmaceuticals Ltd (RCE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$102 Change of Director's Interest Notice 25 Feb 2021 6:46PM n/a $0.335 n/a
$102 Change of Director's Interest Notice 25 Feb 2021 6:44PM n/a $0.335 n/a
$102 Change of Director's Interest Notice 25 Feb 2021 6:44PM n/a $0.335 n/a
$102 Cleansing Statement 25 Feb 2021 6:41PM n/a $0.335 n/a
$102 Appendix 2A 25 Feb 2021 6:37PM n/a $0.335 n/a
$102 Appendix 4D and Half Yearly Report 25 Feb 2021 5:46PM n/a $0.335 n/a
$102 Recce Applies for Dual Listing on Frankfurt Stock Exchange 24 Feb 2021 9:49AM $1.050 $0.335 fallen by 68.10%
$102 Appendix 3G 22 Feb 2021 6:06PM $1.030 $0.335 fallen by 67.48%
$102 Fiona Stanley Hospital Phase I/II Clinical Trial Agreement 16 Feb 2021 9:20AM $1.110 $0.335 fallen by 69.82%
$102 Further Encouraging COVID Results at Doherty 12 Feb 2021 9:44AM $1.030 $0.335 fallen by 67.48%
$102 R&D Incentive Rebate Received 3 Feb 2021 12:12PM $1.010 $0.335 fallen by 66.83%
$102 Appendix 4C and Activity Report 28 Jan 2021 11:18AM $1.020 $0.335 fallen by 67.16%
$102 Cleansing Statement 19 Jan 2021 6:42PM $1.030 $0.335 fallen by 67.48%
$102 Appendix 2A 19 Jan 2021 6:39PM $1.030 $0.335 fallen by 67.48%
$102 Corporate Presentation 8 Jan 2021 9:01AM $1.080 $0.335 fallen by 68.98%
$102 Positive Intranasal Animal Data against SARS-CoV-2 in Study 23 Dec 2020 9:47AM $1.080 $0.335 fallen by 68.98%
$102 Business Update 16 Dec 2020 11:51AM $1.155 $0.335 fallen by 71%
$102 Change of Director's Interest Notice 11 Dec 2020 12:20PM $1.190 $0.335 fallen by 71.85%
$102 RCE Awarded AusIndustry Advanced Overseas Anti-Viral Finding 8 Dec 2020 9:30AM $1.210 $0.335 fallen by 72.31%
$102 Cleansing Statement 4 Dec 2020 5:41PM $1.220 $0.335 fallen by 72.54%
$102 Appendix 2A 4 Dec 2020 5:41PM $1.220 $0.335 fallen by 72.54%
$102 Results of Meeting 30 Nov 2020 10:52AM $1.115 $0.335 fallen by 69.96%
$102 RCE AGM Presentation 30 Nov 2020 8:49AM $1.115 $0.335 fallen by 69.96%
$102 Recce Awarded AusIndustry Advanced Overseas (R&D) Finding 26 Nov 2020 9:51AM $1.130 $0.335 fallen by 70.35%
$102 Anti-Viral Patent Granted in Japan for RECCE Anti-Infectives 23 Nov 2020 10:01AM $1.085 $0.335 fallen by 69.12%

376 - 400 of 729 results

Page 16 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.